Minggang Lu
Direktor/Vorstandsmitglied bei Lu Daopei Medical Group Holding Ltd.
Profil
Minggang Lu is currently the Director at Beijing Ludaopei Biotechnology Co., Ltd, the Executive Director at Lu Daopei Medical Group Holding Ltd., and the Director at Beijing Yizhuang Lu Daopei Hospital.
Previously, he served as the Director-Ophthalmology Center at Jiangsu University from 1998 to 2017 and as the Director at Beijing Lu Daopei Hematology Hospital Co. Ltd.
Aktive Positionen von Minggang Lu
| Unternehmen | Position | Beginn |
|---|---|---|
Lu Daopei Medical Group Holding Ltd.
 Lu Daopei Medical Group Holding Ltd. Hospital/Nursing ManagementHealth Services Lu Daopei Medical Group Holding Ltd. provides hematology treatment services. It built full-cycle hematology specialty service capabilities by integrating various treatments such as HSCTs, chemotherapy, targeted therapy, immunotherapy, and a combination of these, and offering hematology esoteric testing services throughout the whole diagnosis and treatment course. The company was founded on October 05, 2021 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 20.07.2022 |
| Beijing Yizhuang Lu Daopei Hospital | Direktor/Vorstandsmitglied | - |
| Beijing Ludaopei Biotechnology Co., Ltd | Direktor/Vorstandsmitglied | 01.11.2017 |
Ehemalige bekannte Positionen von Minggang Lu
| Unternehmen | Position | Ende |
|---|---|---|
| Jiangsu University | Corporate Officer/Principal | 01.06.2017 |
| Beijing Lu Daopei Hematology Hospital Co. Ltd. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Lu Daopei Medical Group Holding Ltd.
Lu Daopei Medical Group Holding Ltd. Hospital/Nursing ManagementHealth Services Lu Daopei Medical Group Holding Ltd. provides hematology treatment services. It built full-cycle hematology specialty service capabilities by integrating various treatments such as HSCTs, chemotherapy, targeted therapy, immunotherapy, and a combination of these, and offering hematology esoteric testing services throughout the whole diagnosis and treatment course. The company was founded on October 05, 2021 and is headquartered in Beijing, China. | Health Services |
| Beijing Yizhuang Lu Daopei Hospital | |
| Beijing Ludaopei Biotechnology Co., Ltd | |
| Beijing Lu Daopei Hematology Hospital Co. Ltd. |
